A 4-Week, Dose Ranging Double-Blinded Randomized Placebo-controlled, Parallel group study to assess the Safety and Efficacy of ADP356 in Obese Patients

  • Anderson, James (PI)
  • Reynolds, L (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/05 → 12/31/06